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Expression of the Na1/myo-inositol cotransporter in the juxtaglo-
merular region. Myo-inositol is a major compatible osmolyte in
the renal medulla and is accumulated in cells under hypertonic
conditions by uptake via a Na1/myo-inositol cotransporter
(SMIT). SMIT is regulated by extracellular osmolarity at the
transcription level. We investigated localization of SMIT in rat
kidney by immunohistochemical staining using an anti-SMIT-
antibody raised against a synthetic peptide corresponding to part
of SMIT and by in situ hybridization. SMIT protein localized
predominantly to the basolateral membranes of cells of the thick
ascending limb of Henle (TAL) and inner medullary collecting
duct (IMCD). Macula densa (MD) cells, identified as the Tamm-
Horsfall-protein (THP)-unreactive cells surrounded by THP-
reactive TAL cells, also stained for anti-SMIT. In situ hybridiza-
tion yielded the intense SMIT signals in the TAL and IMCD and
also in the juxtaglomerular (JG) region. Prior loading of the
animal with a high concentration of NaCl rapidly induced SMIT
mRNA; furosemide down-regulated it. The high level of SMIT
expression suggests that MD cells are exposed to hypertonicity at
the basolateral surface. Because SMIT expression seemed to be
proportional to the magnitude of NaCl reabsorption, it may be a
good marker for examination of the tubuloglomerular feedback
mechanism in vivo.
Myo-inositol is a major osmolyte in the renal medulla, in
some kidney-derived cell lines [1], and in brain cells [2]. A
cDNA encoding a Na1/myo-inositol cotransporter (SMIT)
was isolated from Madin-Darby canine kidney cells [3]. The
abundance of SMIT mRNA and the transcription rate of
the SMIT gene increases when cells are cultured in hyper-
tonic medium, suggesting that transcription is the primary
step in regulation of myo-inositol transport by hypertonicity
[4].
The other predominant osmolytes in renal medulla are
sorbitol, betaine, and glycerophosphorylcholine. The distri-
bution of these osmolytes in the kidney corresponds largely
to the corticomedullary osmotic gradient, with the highest
concentration found in the inner medulla (IM) and papil-
lary segments [5]. Myo-inositol is the only osmolyte found
in substantial amounts in the cortex and the outer medulla
(OM) in addition to the IM [6]. SMIT mRNA abundance is
highest in the OM, and low but significant amounts of
SMIT mRNA are present in the cortex [7]. SMIT mRNA in
both cortex and medulla is induced by dehydration. Cul-
tured rat mesangial cells respond to extracellular hyperto-
nicity by increasing myo-inositol transport activity and
accumulating myo-inositol [8]. It is probable that a fraction
of the SMIT found in the cortex derives from mesangial
cells because extraglomerular mesangial cells might be
faced with hypertonic stress [9].
In a recent in situ hybridization study, SMIT mRNA was
found predominantly in the thick ascending limb of Henle
(TAL) and in the IM collecting duct (IMCD) [10], with
significant signals also in the juxtaglomerular (JG) region.
This study focuses on localization and regulation of SMIT
expression in the JG region.
METHODS
Male Sprague-Dawley rats (about 150 g) were used.
Some were Na loaded by administration of 1.5 ml 1.5 M
NaCl/100 g i.p. In some experiments, furosemide (20
mg/kg, i.p.) was administered simultaneously with NaCl
loading. Organs were fixed by transcardial perfusion with
4% paraformaldehyde.
SMIT protein was localized in the kidney with an anti-
SMIT-antibody raised in rabbits against a synthetic peptide,
PASVWYWCADQVIVQRVLAAKNIA, which corre-
sponds to amino acids 271 to 295 of SMIT [3]. Kidney
tissues were dehydrated through a graded ethanol series
and embedded in paraffin. Histological sections were pro-
cessed by an indirect immunoperoxidase technique using a
commercial kit (Vectastain ABC kit; Vector Laboratories,
Burlingame, CA, USA) with antibodies against SMIT and
human Tamm-Horsfall protein (THP; Chemicon Interna-
tional, CA, USA).
SMIT mRNA in the kidney was localized by in situ
hybridization. A partial clone of rat SMIT cDNA was used
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to synthesize a cRNA probe [10], and in situ hybridization
was carried out essentially as reported previously [10]. The
probe concentration was 1 3 106 cpm/200 ml per slide.
Slides were exposed initially to x-ray film for three days to
provide an indication of the intensity of the hybridization
signal. They were then coated with Kodak NTB-2 emulsion
diluted 1:1 with water. Sections were exposed at 4°C for two
to three weeks in a tightly sealed dark boxes and then were
developed in Kodak D-19, fixed with photographic fixer,
washed with water, and counterstained with hematoxylin
and eosin to allow morphological identification.
RESULTS AND DISCUSSION
Staining for anti-SMIT-antibody localized the SMIT
protein predominantly to the TAL and IMCD. Although
signals in the tubular cells were predominantly along the
basolateral membrane, there seemed to be significant sig-
nals along the apical membrane of TAL. Specificity of the
antibody was demonstrated by absence of signal when
anti-SMIT-antibody was preabsorbed with specific antigen.
In the cortex, immunostaining for anti-SMIT was intense in
the JG region and in the cortical part of the TAL. To
localize SMIT protein in the JG region, macula densa
(MD) cells were identified as THP-unreactive cells sur-
rounded by THP-reactive TAL cells [11]. The THP-unre-
active cells stained clearly for anti-SMIT. Thus, SMIT
protein is apparently present in MD cells even under
normal conditions.
Autoradiographs generated from sections after in situ
hybridization with the SMIT probe revealed intense signals
in the OM. There were also significant signals in the IM
and papilla of the kidney, although these were less intense
than in the OM. A punctate pattern of the signal was
apparent in the cortex.
Microscopic examination of emulsion-coated kidney sec-
tions revealed the most intense SMIT hybridization signals
in the TAL. The radial striations running outward from the
OM, which were mainly cortical TAL, were apparent in the
cortex. MD cells, which were identified by immunostaining
for THP in the consecutive section, were also labeled in the
cortex. The MD signals seemed to be as intense as those in
the TAL.
NaCl loading dramatically induced the expression of
SMIT in TAL and MD. The magnitude of the increase in
the MD appeared to be similar to that in the TAL. Close
scrutiny of the JG region showed that extraglomerular
mesangial cells, very close to the MD, appear to express
SMIT. Interestingly, there seemed to be a decreasing
gradient of expression to the JG interstitium. Furosemide
abolished the increase in SMIT mRNA elicited by NaCl
injection. The attenuation of the increased mRNA was
equivalent in TAL and MD.
The study shows that SMIT mRNA is expressed highly
throughout the TAL as well as the MD and is induced by
acute administration of NaCl. Because SMIT mRNA is
regulated in an osmolarity-dependent manner [4], it is
suggested that these cells might be exposed to hyperosmo-
larity. The mechanisms of NaCl absorption across MD cells
are considered to be qualitatively similar to those of TAL
cells [12]. These cells actively reabsorb sodium chloride
from the tubular fluid. The Na/K/2Cl transporter in the
luminal plasma membrane is mainly responsible for NaCl
uptake in this segment, which is energized by the action of
the Na/K-ATPase in the basolateral membrane. The TAL
epithelium is virtually completely impermeable to osmotic
water flow. The MD epithelium is also relatively water
impermeable, with a hydraulic conductivity similar to that
of cortical collecting tubules in the absence of vasopressin
[13]. We assume that the osmolarity close to the basolateral
plasma membrane of the tubular cells, that is, peritubular
osmolarity [14], is very high throughout the TAL and MD.
The peritubular osmolarity is supposed to change with the
magnitude of NaCl reabsorption. Our results are consistent
with this hypothesis. In the salt-loaded rat, NaCl reabsorp-
tion increases, thus elevating intracellular and/or peritubu-
lar osmolarity, which induces the SMIT expression
throughout this segment. There is direct evidence of peri-
tubular hypertonicity for MD cells. The basolateral side of
the cells is in contact with the JG interstitium, which is the
wedge-shaped compartment formed by the afferent and
efferent arterioles. In Amphiuma, the [Cl2] in the JG
interstitium exceeds plasma levels (100 mM) at all tubular
flow rates and increased to over 600 mM with increasing
flow rate. Thus, NaCl transport into the interstitium pro-
ceeds through the water impermeable tubular epithelium,
which results in basolateral hypertonicity during elevated
flow rates.
A group of the JG interstitial cells are referred to as
extraglomerular mesangial cells [12] because these cells are
morphologically indistinguishable from mesangial cells and
actually extend into the stalk of mesangium. Cultured rat
mesangial cells accumulate myo-inositol in response to
extracellular hyperosmolarity and express a Na1/myo-ino-
sitol cotransporter that is regulated by tonicity [8]. It is
probable that the increased myo-inositol and SMIT mRNA
observed in dehydrated renal cortex [7] is, at least partly,
derived from mesangial cells. SMIT expression is clearly
evident in the JG region and is induced by NaCl loading.
The expression seems to be relatively high in the MD, with
a decreasing gradient of expression to the JG interstitium.
Although the MD cells have strong signals for SMIT,
extraglomerular mesangial cells, close to the tubular cells,
also appear to express SMIT that is induced by NaCl
loading. Thus, the results of in situ hybridization are
consistent with our previous in vitro studies on mesangial
cells.
The diuretic effect of furosemide is mainly due to its
ability to bind to and inhibit the Na/K/2Cl transporter
located in the luminal plasma membrane of the TAL and
MD cells. Micropuncture of the early distal convoluted
Yamauchi et al: Expression of the myo-inositol transporterS-184
tubule reveals that furosemide increases luminal osmolarity
as well as Na, Cl, and K concentrations [15]. Because SMIT
expression was diminished by furosemide, it is apparently
independent of the luminal osmolarity. The decreased
expression of SMIT after furosemide suggests that the
intracellular and/or basolateral osmolarity is reduced by
inhibition of NaCl reabsorption from the lumen.
In summary, SMIT is present predominantly in the TAL
and MD, with less intense signals in the IMCD. In the JG
region, extraglomerular mesangial cells also appear to
express SMIT. NaCl loading increased, and furosemide
decreased SMIT expression in the MD. The high level of
SMIT expression suggests that MD cells are exposed to
hypertonicity on basolateral surface. Because SMIT expres-
sion seemed to be proportional to the magnitude of NaCl
reabsorption, it may be a good marker for examination of
tubuloglomerular feedback mechanism in vivo.
APPENDIX
Abbreviations used in this article are: IM, inner medulla; IMCD, inner
medullary collecting duct; JG, juxtaglomerular; MD, macula densa; OM,
outer medulla; SMIT, Na1/myo-inositol cotransporter; TAL, thick ascend-
ing limb; THP, Tamm-Horsfall-protein.
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